Attached files
| file | filename |
|---|---|
| 10-K - 10-K - SPECTRUM PHARMACEUTICALS INC | a55483e10vk.htm |
| EX-21 - EX-21 - SPECTRUM PHARMACEUTICALS INC | a55483exv21.htm |
| EX-31.2 - EX-31.2 - SPECTRUM PHARMACEUTICALS INC | a55483exv31w2.htm |
| EX-32.1 - EX-32.1 - SPECTRUM PHARMACEUTICALS INC | a55483exv32w1.htm |
| EX-31.1 - EX-31.1 - SPECTRUM PHARMACEUTICALS INC | a55483exv31w1.htm |
| EX-23.1 - EX-23.1 - SPECTRUM PHARMACEUTICALS INC | a55483exv23w1.htm |
| EX-32.2 - EX-32.2 - SPECTRUM PHARMACEUTICALS INC | a55483exv32w2.htm |
| EX-10.29 - EX-10.29 - SPECTRUM PHARMACEUTICALS INC | a55483exv10w29.htm |
| EX-10.37 - EX-10.37 - SPECTRUM PHARMACEUTICALS INC | a55483exv10w37.htm |
| EX-10.36 - EX-10.36 - SPECTRUM PHARMACEUTICALS INC | a55483exv10w36.htm |
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference into the Company’s previously filed
Registration Statements on Form S-3 (Nos. 333-163366, 333-150260, 333-142628, 333-135029,
333-125208, 333-121612, 333-115759, 333-110103, 333-108658, 333-105814, 333-102587, 333-64444,
333-64432, 333-60966, 333-51388, 333-42852, 333-38710, 333-37180, 333-92855, 333-73009, 333-52331,
333-37585) and Form S-8 (Nos. 333-160312, 333-160705, 333-164014, 333-134566, 333-119833,
333-106427, 333-54246, 333-30345), of our audit report on the consolidated financial statements
dated March 31, 2009 and April 2, 2010 as it relates to Note 2, included in Spectrum
Pharmaceuticals, Inc.’s Form 10-K for the year ended December 31, 2009.
/s/ Kelly & Company
Kelly & Company
Costa Mesa, California
April 2, 2010
Costa Mesa, California
April 2, 2010